₹705.95-33.05 (-4.47%)
04:00 PM, 12-Dec-2024₹706.05-30.80 (-4.18%)
03:52 PM, 12-Dec-2024BSE : 532531
NSE : STAR
Sector : Health care
ISIN Code : INE939A01011
Last Updated: 12-Dec-2024 | 04:00 PM IST
Market Cap (₹ Cr) | 6,506 |
Traded Value (₹ Cr) | 2.65 |
Volume (Shares) | 37,484 |
Face Value (₹) | 10 |
52-Week High (₹) | 785.85 |
52-Week High Date | 10-Dec-2024 |
52-Week Low (₹) | 233.60 |
52-Week Low Date | 12-Dec-2023 |
All Time High (₹) | 785.85 |
All Time High Date | 10-Dec-2024 |
All Time Low (₹) | 25.72 |
All Time Low Date | 05-Mar-2009 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 6,507 |
EPS - TTM (₹) [C] | 22.36 |
P/E Ratio (X) [C] | 31.58 |
Face Value (₹) | 10 |
Latest Dividend (%) | 25.00 |
Latest Dividend Date | 09-Sep-2024 |
Dividend Yield (%) | 0.34 |
Book Value Share (₹) [C] | 246.48 |
P/B Ratio (₹) [C] | 2.86 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Quant Small Cap Fund - (G) | 546.36 | 33,40,936 | 2.01 |
Quant Small Cap Fund - (IDCW) | 546.36 | 33,40,936 | 2.01 |
Quant Small Cap Fund - Direct (G) | 546.36 | 33,40,936 | 2.01 |
Quant Small Cap Fund - Direct (IDCW) | 546.36 | 33,40,936 | 2.01 |
Quant Active Fund (G) | 232.55 | 14,22,000 | 2.19 |
Quant Active Fund (IDCW) | 232.55 | 14,22,000 | 2.19 |
Quant Active Fund - Direct (G) | 232.55 | 14,22,000 | 2.19 |
Quant Active Fund - Direct (IDCW) | 232.55 | 14,22,000 | 2.19 |
Aditya Birla SL Flexi Cap Fund (G) | 147.71 | 9,03,236 | 0.66 |
Aditya Birla SL Flexi Cap Fund (IDCW) | 147.71 | 9,03,236 | 0.66 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 702.80 753.90 |
Week Low/High (₹) | 638.17 753.90 |
Month Low/High (₹) | 591.33 753.90 |
Year Low/High (₹) | 233.41 753.90 |
All time Low/High (₹) | 25.72 753.90 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 8.55% | 8.50% | -0.58 | -0.65% |
1 Month | 10.16% | 9.79% | 3.32 | 2.79% |
3 Month | 19.20% | 19.16% | -2.02 | -3.31% |
6 Month | 73.79% | 73.96% | 6.11 | 5.26% |
1 Year | 194.19% | 194.62% | 16.88 | 17.42% |
3 Year | 250.19% | 249.93% | 38.28 | 40.19% |
Executive Chairman & M.D. : Arun Kumar
Company Sec. & Compli. Officer : Manjula Ramamurthy
Non-Exec. & Independent Dir. : Homi Rustam Khusrokhan
Managing Director & Group CEO : Badree Komandur
Non-Exec. & Independent Dir. : Kausalya Santhanam
Non-Exec. & Independent Dir. : Subir Chakraborty
Non-Exec. & Independent Dir. : Ameet Hariani
Director (Business Developmnt) : Aditya Kumar
Registered Office: No 201 Devavrata Sector 17, Vashi,Navi Mumbai,Maharashtra-400703 Ph: 91-22-27892924/27893199
Email:investors@strides.com
1. What's the Strides Pharma Science Ltd share price today?
Strides Pharma Science Ltd share price was Rs 705.95 at 04:00 PM IST on 12th Dec 2024. Strides Pharma Science Ltd share price was down by 4.47% from the previous closing price of Rs 739.00. Strides Pharma Science Ltd share price trend:
2. How can I quickly analyse the performance of the Strides Pharma Science Ltd stock?
The performance of the Strides Pharma Science Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Strides Pharma Science Ltd?
Strides Pharma Science Ltd has a market capitalisation of Rs 6,506 crore.
4. What is Strides Pharma Science Ltd's 52-week high/low share price?
The Strides Pharma Science Ltd’s 52-week high share price is Rs 785.85 and 52-week low share price is Rs 233.60.
5. Is the Strides Pharma Science Ltd profitable?
On a consolidated basis, Strides Pharma Science Ltd reported a profit of Rs 15.31 crore on a total income of Rs 633.51 crore for the quarter ended 2024. For the year ended Sep 2024, Strides Pharma Science Ltd had posted a profit of Rs 93.66 crore on a total income of Rs 1,229.52 crore.
6. Which are Strides Pharma Science Ltd’s peers in the Health care sector?
Strides Pharma Science Ltd’s top 5 peers in the Health care sector are FDC, Shilpa Medicare, SPARC, Strides Pharma, Supriya Lifesci., Innova Captab, Aarti Pharma.
7. Who owns how much in Strides Pharma Science Ltd?
Key changes to the Strides Pharma Science Ltd shareholding are as follows: